M05BB03 · Musculo-skeletal system
Vantavo (previously Alendronate sodium and colecalciferol, MSD)
Indications
Treatment of postmenopausal osteoporosis in patients at risk of vitamin-D insufficiency. Vantavo reduces the risk of vertebral and hip fractures. Treatment of postmenopausal osteoporosis in patients who are not receiving vitamin-D supplementation and are at risk of vitamin-D insufficiency. Vantavo reduces the risk of vertebral and hip fractures.
Composition
- Active substance
- alendronic acid, colecalciferol
- International name (INN)
- alendronic acid;colecalciferol
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Vantavo (previously Alendronate sodium and colecalciferol, MSD)
- Active substance
- alendronic acid, colecalciferol
- ATC code
- M05BB03